despite the fact that some of the claims have already been proved to be true? That seems like an oversight.
Interestingly it appears that even QIN's pet brokers are starting to get twitchy - Argonaut have just downgraded their recommendation from buy to hold and cut their price target by 55%. And this after their debt rating was downgraded - it appears that other analysts are less dismissive of the entirely valid concerns that Glaucus raised.
QIN Price at posting:
$1.13 Sentiment: Sell Disclosure: Held
